The impact of casirivimab-imdevimab antibody cocktail in patients amidst and post COVID 19 treatment: A retro-prospective comparative study in India

BACKGROUND: Monoclonal antibodies have gained attention in developing countries owing to its benefits portrayed by few clinical trials. However, no studies until now have been undergone in India. METHODS: A retro-prospective comparative observational study was conducted in symptomatic COVID19 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Joy, Aneesh Puthiyedath, Augustine, Anitha Theresa, Karattuthodi, Mohammed Salim, Parambil, Jaffer Chalil, Chandrasekher, Dilip, Danisha, P., Panakkal, Linu Mohan, Joshi, Madhav A., Azharul Haque, K.T., Mohammed Izudheen, Irshad K., Badaruddeen, Shadia, John, Riya Sara, Murali, Sarath, Thomas, Ardhra Rose, Sahla, Fathimath, Ahmed Unni, Shahir Ahmed KV., Ahmed, Raseel Omar, Cholamugath, Shinu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. on behalf of INDIACLEN. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767937/
https://www.ncbi.nlm.nih.gov/pubmed/35071825
http://dx.doi.org/10.1016/j.cegh.2022.100967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767937/
https://www.ncbi.nlm.nih.gov/pubmed/35071825
http://dx.doi.org/10.1016/j.cegh.2022.100967

Ejemplares similares